[Ethics and research: ethical considerations in clinical research].

Acta psychiatrica Belgica Pub Date : 1995-01-01
H D'Haenen
{"title":"[Ethics and research: ethical considerations in clinical research].","authors":"H D'Haenen","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Two subjects are discussed: the use of placebo controls in clinical trials and informed consent. Particularly in trials of drugs for disorders for which there exist effective treatments, the use of placebo is still controversial, although anyhow in violation of the Declaration of Helsinki. Informed consent aims at giving a subject all the necessary information to allow him to decide, with full knowledge, whether to accept a particular treatment or experimental protocol. Its importance would seem, albeit essential, to be rather illusory.</p>","PeriodicalId":75415,"journal":{"name":"Acta psychiatrica Belgica","volume":"95 6","pages":"332-6"},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta psychiatrica Belgica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Two subjects are discussed: the use of placebo controls in clinical trials and informed consent. Particularly in trials of drugs for disorders for which there exist effective treatments, the use of placebo is still controversial, although anyhow in violation of the Declaration of Helsinki. Informed consent aims at giving a subject all the necessary information to allow him to decide, with full knowledge, whether to accept a particular treatment or experimental protocol. Its importance would seem, albeit essential, to be rather illusory.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[伦理与研究:临床研究中的伦理考虑]。
讨论了两个主题:在临床试验中使用安慰剂对照和知情同意。特别是在已有有效治疗方法的疾病的药物试验中,使用安慰剂仍然存在争议,尽管无论如何都违反了《赫尔辛基宣言》。知情同意的目的是向受试者提供所有必要的信息,使其能够在充分了解的情况下决定是否接受特定的治疗或实验方案。它的重要性虽然至关重要,但似乎相当虚幻。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Problems of process-efficiency studies in psychotherapy. [Problem of indications in psychotherapy]. Costs and benefits of psychotherapy. [Psychotherapy in the institutional environment]. [Psychotherapy in children and youths].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1